Cancer cell-soluble factors reprogram mesenchymal stromal cells to slow cycling, chemoresistant cells with a more stem-like state

被引:26
作者
El-Badawy, Ahmed [1 ]
Ghoneim, Mohamed A. [2 ]
Gabr, Mahmoud M. [2 ]
Salah, Radwa Ayman [1 ]
Mohamed, Ihab K. [3 ]
Amer, Marwa [1 ]
El-Badri, Nagwa [1 ]
机构
[1] Zewail City Sci & Technol, Ctr Excellence Stem Cells & Regenerat Med CESC, Giza 12588, Egypt
[2] Mansoura Univ, Urol & Nephrol Ctr, Mansoura, Egypt
[3] Ain Shams Univ, Dept Zool, Fac Sci, Cairo, Egypt
来源
STEM CELL RESEARCH & THERAPY | 2017年 / 8卷
关键词
TUMOR-GROWTH; IN-VITRO; GENERATES CELLS; BETA-CATENIN; BONE-MARROW; TRANSITION; EXPRESSION; PROGRESSION; LEUKEMIA; PROMOTE;
D O I
10.1186/s13287-017-0709-9
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Background: Mesenchymal stem cells (MSCs) play different roles in modulating tumor progression, growth, and metastasis. MSCs are recruited to the tumor site in large numbers and subsequently have an important microenvironmental role in modulating tumor progression and drug sensitivity. However, the effect of the tumor microenvironment on MSC plasticity remains poorly understood. Herein, we report a paracrine effect of cancer cells, in which they secrete soluble factors that promote a more stem-like state in bone marrow mesenchymal stem cells (BM-MSCs). Methods: The effect of soluble factors secreted from MCF7, Hela, and HepG2 cancer cell lines on BM-MSCs was assessed using a Transwell indirect coculture system. After 5 days of coculture, BM-MSCs were characterized by flow cytometry for surface marker expression, by qPCR for gene expression profile, and by confocal immunofluorescence for marker expression. We then measured the sensitivity of cocultured BM-MSCs to chemotherapeutic agents, their cell cycle profile, and their response to DNA damage. The sphere formation, invasive properties, and in-vivo performance of BM-MSCs after coculture with cancer cells were also measured. Results: Indirect coculture of cancer cells and BM-MSCs, without direct cell contact, generated slow cycling, chemoresistant spheroid stem cells that highly expressed markers of pluripotency, cancer cells, and cancer stem cells (CSCs). They also displayed properties of a side population and enhanced sphere formation in culture. Accordingly, these cells were termed cancer-induced stem cells (CiSCs). CiSCs showed a more mesenchymal phenotype that was further augmented upon TGF-beta stimulation and demonstrated a high expression of the beta-catenin pathway and ALDH1A1. Conclusions: These findings demonstrate that MSCs, recruited to the tumor microenvironment in large numbers, may display cellular plasticity, acquire a more stem-like state, and acquire some properties of CSCs upon exposure to cancer cell-secreted factors. These acquired characteristics may contribute to tumor progression, survival, and metastasis. Our findings provide new insights into the interactions between MSCs and cancer cells, with the potential to identify novel molecular targets for cancer therapy.
引用
收藏
页数:20
相关论文
共 120 条
  • [41] Cancer Stem Cells: Cell Culture, Markers, and Targets for New Therapies
    Gilbert, Candace A.
    Ross, Alonzo H.
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 2009, 108 (05) : 1031 - 1038
  • [42] ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome
    Ginestier, Christophe
    Hur, Min Hee
    Charafe-Jauffret, Emmanuelle
    Monville, Florence
    Dutcher, Julie
    Brown, Marty
    Jacquemier, Jocelyne
    Viens, Patrice
    Kleer, Celina G.
    Liu, Suling
    Schott, Anne
    Hayes, Dan
    Birnbaum, Daniel
    Wicha, Max S.
    Dontu, Gabriela
    [J]. CELL STEM CELL, 2007, 1 (05) : 555 - 567
  • [43] An autocrine TGF-β/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition
    Gregory, Philip A.
    Bracken, Cameron P.
    Smith, Eric
    Bert, Andrew G.
    Wright, Josephine A.
    Roslan, Suraya
    Morris, Melanie
    Wyatt, Leila
    Farshid, Gelareh
    Lim, Yat-Yuen
    Lindeman, Geoffrey J.
    Shannon, M. Frances
    Drew, Paul A.
    Khew-Goodall, Yeesim
    Goodall, Gregory J.
    [J]. MOLECULAR BIOLOGY OF THE CELL, 2011, 22 (10) : 1686 - 1698
  • [44] Cancer stem cells: mirage or reality?
    Gupta, Piyush B.
    Chaffer, Christine L.
    Weinberg, Robert A.
    [J]. NATURE MEDICINE, 2009, 15 (09) : 1010 - 1012
  • [45] Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
    Gupta, Piyush B.
    Onder, Tamer T.
    Jiang, Guozhi
    Tao, Kai
    Kuperwasser, Charlotte
    Weinberg, Robert A.
    Lander, Eric S.
    [J]. CELL, 2009, 138 (04) : 645 - 659
  • [46] GWENDAL L, 2016, BBA-REV CANCER, V1866, P290, DOI DOI 10.1016/J.BBCAN.2016.10.004
  • [47] PRIMARY BIOASSAY OF HUMAN TUMOR STEM-CELLS
    HAMBURGER, AW
    SALMON, SE
    [J]. SCIENCE, 1977, 197 (4302) : 461 - 463
  • [48] Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
    Hanahan, Douglas
    Coussens, Lisa M.
    [J]. CANCER CELL, 2012, 21 (03) : 309 - 322
  • [49] Normal and malignant epithelial cells with stem-like properties have an extended G2 cell cycle phase that is associated with apoptotic resistance
    Harper, Lisa J.
    Costea, Daniela Elena
    Gammon, Luke
    Fazil, Bilal
    Biddle, Adrian
    Mackenzie, Ian C.
    [J]. BMC CANCER, 2010, 10
  • [50] Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer
    Hermann, Patrick C.
    Huber, Stephan L.
    Herrler, Tanja
    Aicher, Alexandra
    Ellwart, Joachim W.
    Guba, Markus
    Bruns, Christiane J.
    Heeschen, Christopher
    [J]. CELL STEM CELL, 2007, 1 (03) : 313 - 323